tiprankstipranks
Cogent Biosciences (COGT)
NASDAQ:COGT
US Market
Holding COGT?
Track your performance easily

Cogent Biosciences (COGT) Financial Statements

539 Followers

Cogent Biosciences Financial Overview

Cogent Biosciences's market cap is currently ―. The company's EPS TTM is $-2.477; its P/E ratio is -3.71; Cogent Biosciences is scheduled to report earnings on March 18, 2025, and the estimated EPS forecast is $-0.59. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue---$ 950.00K-
Gross Profit---$ 950.00K-
EBIT$ -70.63M$ -58.95M$ -62.40M$ -58.23M$ -59.58M
EBITDA$ -69.54M$ -56.47M$ -61.34M$ -57.43M$ -58.73M
Net Income Common Stockholders$ -70.63M$ -58.95M$ -58.35M$ -54.37M$ -55.38M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 335.52M$ 363.22M$ 435.74M$ 265.71M$ 279.04M
Total Assets$ 384.02M$ 429.94M$ 476.11M$ 313.44M$ 355.45M
Total Debt$ 17.83M$ 18.18M$ 18.52M$ 18.85M$ 19.17M
Net Debt$ -317.69M$ -345.03M$ -417.22M$ -246.86M$ -259.87M
Total Liabilities$ 69.36M$ 56.71M$ 53.78M$ 55.63M$ 52.55M
Stockholders Equity$ 314.66M$ 319.14M$ 260.22M$ 257.80M$ 302.90M
Cash Flow-
Free Cash Flow$ -52.26M$ -42.85M$ -52.60M$ -44.38M$ -38.09M
Operating Cash Flow$ -51.98M$ -42.70M$ -52.53M$ -44.07M$ -37.97M
Investing Cash Flow$ 60.19M$ -84.63M$ 1.04M$ 10.49M$ -90.54M
Financing Cash Flow$ 624.00K$ -256.00K$ 214.06M-$ 1.00M
Currency in USD

Cogent Biosciences Earnings and Revenue History

Cogent Biosciences Debt to Assets

Cogent Biosciences Cash Flow

Cogent Biosciences Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis